东阿阿胶：科技创新站“C位”，赋能健康产业新征程

Core Viewpoint - The company is focusing on technological innovation as a key driver for high-quality development, integrating traditional wisdom with modern technology to enhance its role in the health industry and contribute to national health strategies [1][2][9]. Group 1: Technological Innovation Strategy - The company has upgraded its research and development model from "point breakthroughs" to "system reconstruction," emphasizing a comprehensive approach to innovation [1]. - The implementation of the "1+3+N" R&D innovation strategy aims to establish a robust innovation ecosystem, including a national engineering technology research center and partnerships with various universities [4][5]. - The establishment of two academic workstations with renowned academicians signifies a commitment to advancing research capabilities and addressing key technological challenges in the industry [6][7]. Group 2: Business Growth Model - The company has adopted a "dual-wheel drive" business growth model, focusing on both pharmaceuticals and health consumer products to become a trusted leader in health supplements [2]. - The "1246" model introduced by the parent group has guided significant restructuring efforts to enhance operational efficiency and market reach [2]. Group 3: Collaborative Research and Development - Collaborations with institutions like China Agricultural University and Jiangnan University aim to create high-value research hubs for raw materials and health consumer products [4][5]. - The integration of academic resources and research capabilities through the "N Union" initiative is designed to fill gaps in the existing innovation framework and foster collaborative projects [5]. Group 4: Community and Economic Impact - The establishment of academic workstations is expected to attract high-level talent, optimize regional talent structures, and drive economic growth through innovation [8]. - The company's efforts in translating cutting-edge research into practical health products will enhance public access to health benefits derived from technological advancements [8]. Group 5: Conference and Knowledge Sharing - The 2025 East Argo Technology Innovation Conference gathered over 100 experts and scholars to discuss advancements in pharmaceuticals and health consumer products, reinforcing the company's commitment to innovation [9][11]. - Presentations from leading academicians highlighted the importance of integrating traditional and modern scientific approaches to enhance product development and industry standards [11].